Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 219

1.

The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis.

Pelusi S, Girelli D, Rametta R, Campostrini N, Alfieri C, Traglia M, Dongiovanni P, Como G, Toniolo D, Camaschella C, Messa P, Fargion S, Valenti L.

BMC Nephrol. 2013 Feb 22;14:48. doi: 10.1186/1471-2369-14-48.

PMID:
23433094
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis.

Valenti L, Fracanzani AL, Rametta R, Fraquelli M, Soverini G, Pelusi S, Dongiovanni P, Conte D, Fargion S.

J Hepatol. 2012 Dec;57(6):1319-25. doi: 10.1016/j.jhep.2012.07.041. Epub 2012 Aug 8.

PMID:
22885719
[PubMed - indexed for MEDLINE]
3.

HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.

Valenti L, Girelli D, Valenti GF, Castagna A, Como G, Campostrini N, Rametta R, Dongiovanni P, Messa P, Fargion S.

Clin J Am Soc Nephrol. 2009 Aug;4(8):1331-7. doi: 10.2215/CJN.01370209. Epub 2009 Jun 18.

PMID:
19541813
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.

Valenti L, Rametta R, Dongiovanni P, Motta BM, Canavesi E, Pelusi S, Pulixi EA, Fracanzani AL, Fargion S.

PLoS One. 2012;7(11):e48804. doi: 10.1371/journal.pone.0048804. Epub 2012 Nov 5.

PMID:
23144979
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.

Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, Westerman M, Cazzola M, Galanello R.

Haematologica. 2008 Oct;93(10):1473-9. doi: 10.3324/haematol.13342. Epub 2008 Jul 4.

PMID:
18603562
[PubMed - indexed for MEDLINE]
Free Article
6.

Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C.

Caliskan Y, Yelken B, Ozkok A, Gorgulu N, Yazici H, Telci A, Yildiz A.

BMC Nephrol. 2012 Jul 7;13:56. doi: 10.1186/1471-2369-13-56.

PMID:
22768976
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations.

Traglia M, Girelli D, Biino G, Campostrini N, Corbella M, Sala C, Masciullo C, Viganò F, Buetti I, Pistis G, Cocca M, Camaschella C, Toniolo D.

J Med Genet. 2011 Sep;48(9):629-34. doi: 10.1136/jmedgenet-2011-100061. Epub 2011 Jul 23.

PMID:
21785125
[PubMed - indexed for MEDLINE]
8.

Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study.

Galesloot TE, Geurts-Moespot AJ, den Heijer M, Sweep FC, Fleming RE, Kiemeney LA, Vermeulen SH, Swinkels DW.

J Med Genet. 2013 Sep;50(9):593-8. doi: 10.1136/jmedgenet-2013-101673. Epub 2013 Jun 21.

PMID:
23794717
[PubMed - indexed for MEDLINE]
9.

TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals.

Nai A, Pagani A, Silvestri L, Campostrini N, Corbella M, Girelli D, Traglia M, Toniolo D, Camaschella C.

Blood. 2011 Oct 20;118(16):4459-62. doi: 10.1182/blood-2011-06-364034. Epub 2011 Aug 26.

PMID:
21873547
[PubMed - indexed for MEDLINE]
Free Article
10.

Common TMPRSS6 mutations and iron, erythrocyte, and pica phenotypes in 48 women with iron deficiency or depletion.

Lee PL, Barton JC, Khaw PL, Bhattacharjee SY, Barton JC.

Blood Cells Mol Dis. 2012 Feb 15;48(2):124-7. doi: 10.1016/j.bcmd.2011.12.003. Epub 2012 Jan 21.

PMID:
22265928
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients.

Ford BA, Eby CS, Scott MG, Coyne DW.

Kidney Int. 2010 Oct;78(8):769-73. doi: 10.1038/ki.2010.254. Epub 2010 Jul 28.

PMID:
20668427
[PubMed - indexed for MEDLINE]
12.

Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population.

Gan W, Guan Y, Wu Q, An P, Zhu J, Lu L, Jing L, Yu Y, Ruan S, Xie D, Makrides M, Gibson RA, Anderson GJ, Li H, Lin X, Wang F.

Am J Clin Nutr. 2012 Mar;95(3):626-32. doi: 10.3945/ajcn.111.025684. Epub 2012 Feb 1.

PMID:
22301935
[PubMed - indexed for MEDLINE]
Free Article
13.

An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Schmidt PJ, Toudjarska I, Sendamarai AK, Racie T, Milstein S, Bettencourt BR, Hettinger J, Bumcrot D, Fleming MD.

Blood. 2013 Feb 14;121(7):1200-8. doi: 10.1182/blood-2012-09-453977. Epub 2012 Dec 6.

PMID:
23223430
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Iron-deficiency anemia secondary to mutations in genes controlling hepcidin.

Cau M, Melis MA, Congiu R, Galanello R.

Expert Rev Hematol. 2010 Apr;3(2):205-16. doi: 10.1586/ehm.10.2. Review.

PMID:
21083463
[PubMed - indexed for MEDLINE]
15.

Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents.

van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, Nubé MJ, Penne EL, Gaillard CA, Wetzels JF, Wiegerinck ET, Swinkels DW, Blankestijn PJ, Ter Wee PM; CONTRAST Investigators.

PLoS One. 2012;7(7):e39783. doi: 10.1371/journal.pone.0039783. Epub 2012 Jul 13.

PMID:
22808058
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice.

Finberg KE, Whittlesey RL, Andrews NC.

Blood. 2011 Apr 28;117(17):4590-9. doi: 10.1182/blood-2010-10-315507. Epub 2011 Feb 25.

PMID:
21355094
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia.

Beutler E, Van Geet C, te Loo DM, Gelbart T, Crain K, Truksa J, Lee PL.

Blood Cells Mol Dis. 2010 Jan 15;44(1):16-21. doi: 10.1016/j.bcmd.2009.09.001. Epub 2009 Oct 8.

PMID:
19818657
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.

Tessitore N, Girelli D, Campostrini N, Bedogna V, Pietro Solero G, Castagna A, Melilli E, Mantovani W, De Matteis G, Olivieri O, Poli A, Lupo A.

Nephrol Dial Transplant. 2010 Dec;25(12):3996-4002. doi: 10.1093/ndt/gfq321. Epub 2010 Jun 10.

PMID:
20538788
[PubMed - indexed for MEDLINE]
Free Article
19.

Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.

Shinzato T, Abe K, Furusu A, Harada T, Shinzato K, Miyazaki M, Kohno S.

Med Sci Monit. 2008 Sep;14(9):CR431-7.

PMID:
18758412
[PubMed - indexed for MEDLINE]
20.

TMPRSS6, but not TF, TFR2 or BMP2 variants are associated with increased risk of iron-deficiency anemia.

An P, Wu Q, Wang H, Guan Y, Mu M, Liao Y, Zhou D, Song P, Wang C, Meng L, Man Q, Li L, Zhang J, Wang F.

Hum Mol Genet. 2012 May 1;21(9):2124-31. doi: 10.1093/hmg/dds028. Epub 2012 Feb 8.

PMID:
22323359
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk